Global Clinical Trial Imaging Market 2024-2028
Clinical Trial Imaging Market 2024-2028
The clinical trial imaging market is forecasted to grow by USD 551.3 mn during 2023-2028, accelerating at a CAGR of 7.5% during the forecast period. The report on the clinical trial imaging market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing investment in drug discovery, high growth in emerging countries, and adoption of imaging in clinical trials for cancer therapies.
Technavio's clinical trial imaging market is segmented as below:
By Modality
- Computed tomography
- Magnetic resonance imaging
- Ultrasound
- Positron emission tomography
- Others
By End-user
- Contract research organization
- Pharmaceutical and biotechnology companies
- Research and academic institutes
- Medical device manufacturers
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the partnerships and collaborations as one of the prime reasons driving the clinical trial imaging market growth during the next few years. Also, increasing investment on in clinical trials and integration of ai in clinical trial imaging will lead to sizable demand in the market.
The report on the clinical trial imaging market covers the following areas:
- Clinical Trial Imaging Market sizing
- Clinical Trial Imaging Market forecast
- Clinical Trial Imaging Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading clinical trial imaging market vendors that include Alimentiv Inc, ARANZ Medical Ltd, Aster Medical Imaging LLC, Charles River Laboratories International Inc., Clario, ICON plc, Image Core Lab Pvt Ltd, IXICO plc, Median Technologies SA, Medidata, Medpace Holdings Inc., Navitas Life Sciences, Octalsoft, QMENTA Imaging SL, QUANTIFICARE, THIRONA, Vista Diagnostics Ltd, Voiant, WCG Clinical Inc., and Yunu, Inc.. Also, the clinical trial imaging market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.